For instance, in animal models for glaucoma or diabetic retinopathy, the reduced expression of galectin-3 mediated a protective effect on retinal neurons, most likely via decreased neuroinflammation [8,9,10]. This evidence concerns the gene LGALS3 and diabetic retinopathy.